Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPE/1795 stock hub

TPE/1795 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPE/1795is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

62.2B

Taiwan Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPE/1795

In the news

Latest news · TPE/1795

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.7

P25 12P50 15.5P75 22.5

Trailing P/E13.1

P25 14.4P50 18P75 31.9

ROE21

P25 -16.2P50 0.3P75 9.8

ROIC11.1

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPE/1795 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

238

Groups with data

Currency

TWD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	1,099
Employees Change	18%
Employees Change Percent	1.67
Enterprise value	TWD 101.9B
Exchange	Taiwan Stock Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0001795003
Last refreshed	2026-05-10
Market cap	TWD 62.2B
Price	TWD 237
Price currency	TWD
Rev Per Employee	18,661,941.77x
Sector	Healthcare
Sic	2834
Symbol	tpe/1795
Website	https://www.lotuspharm.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.59%
EV Earnings	21.59x
EV/EBIT	16.42x
EV/EBITDA	13.18x
EV/FCF	16.53x
EV/Sales	4.97x
FCF yield	9.91%
Forward P/E	14.67x
P/B ratio	2.61x
P/E ratio	13.11x
P/S ratio	3.03x
PE Ratio10 Y	88.51x
PE Ratio3 Y	16.1x
PE Ratio5 Y	17.68x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	30.26%
EBITDA Margin	37.1%
FCF margin	30.05%
Gross margin	58.05%
Gross Profit	TWD 11.9B
Gross Profit Growth	8.99%
Gross Profit Growth Q	42.77%
Gross Profit Growth3 Y	15.11%
Gross Profit Growth5 Y	20.97%
Net Income	TWD 4.7B
Net Income Growth	-6.82%
Net Income Growth Q	-0.96%
Net Income Growth Years	0%
Net Income Growth3 Y	16.04%
Net Income Growth5 Y	35.67%
Pretax Margin	27.88%
Profit Margin	23.01%
Profit Per Employee	TWD 4.3M
Profitable Years	9
ROA	5.3
Roa5y	8.84
ROCE	6.95
ROE	21
Roe5y	22.4
ROIC	11.09
Roic5y	15.14

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	14.88%
Cagr1y	7.93%
Cagr3y	-3.86%
Cagr5y	27.53%
Div CAGR10	32.37%
Div CAGR3	18.65%
Div CAGR5	75.21%
EPS Growth	-6.19
EPS Growth Q	-0.07
EPS Growth Years	0
EPS Growth3 Y	16.06
EPS Growth5 Y	33.72
FCF Growth	6.23%
FCF Growth Q	-80.3%
FCF Growth3 Y	25.17%
FCF Growth5 Y	32.05%
OCF Growth	21.56%
OCF Growth Q	-12.74%
OCF Growth10 Y	21.38%
OCF Growth3 Y	26.24%
OCF Growth5 Y	30.87%
Revenue Growth	10.36x
Revenue Growth Q	42.03x
Revenue Growth Quarters	1x
Revenue Growth Years	13x
Revenue Growth3 Y	11.91x
Revenue Growth5 Y	13.84x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.28
Assets	TWD 106.2B
Cash	TWD 7.7B
Current Assets	TWD 26.5B
Current Liabilities	TWD 16.9B
Debt	TWD 47.5B
Debt EBITDA	TWD 6.14
Debt Equity	TWD 2
Debt FCF	TWD 7.7
Equity	TWD 23.8B
Interest Coverage	7.07
Liabilities	TWD 82.4B
Long Term Assets	TWD 79.7B
Long Term Liabilities	TWD 65.5B
Net Cash	TWD -39.7B
Net Cash By Market Cap	TWD -63.93
Net Debt EBITDA	TWD 5.22
Net Debt Equity	TWD 1.67
Net Debt FCF	TWD 6.45
Tangible Book Value	TWD -20.4B
Tangible Book Value Per Share	TWD -77.54
WACC	4.59

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.57
Inventory Turnover	1.28
Net Working Capital	TWD 6.1B
Quick ratio	0.92
Working Capital	TWD 9.6B
Working Capital Turnover	TWD 2.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.67%
Dividend Growth	24.34%
Dividend Growth Years	6%
Dividend per share	TWD 2.56
Dividend Years	5
Dividend Yield	1.08%
Ex Div Date	2025-08-11
Last Dividend	TWD 5.78
Payout Frequency	Annual
Payout Ratio	32.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	300.43%
1Y total return	7.93%
200-day SMA	255.3
3Y total return	-11.13%
50-day SMA	234.3
50-day SMA vs 200-day SMA	50under200
5Y total return	237.32%
All Time High	369.5
All Time High Change	-35.99%
All Time High Date	2026-02-04
All Time Low	40.5
All Time Low Change	483.95%
All Time Low Date	2018-02-09
ATR	8.15
Beta	0.49
Beta1y	0.42
Beta2y	0.47
Ch YTD	-16.43
High	242
High52	369.5
High52 Date	2026-02-04
High52ch	-35.99%
Low	232.5
Low52	185
Low52 Date	2025-09-15
Low52ch	27.84%
Ma50ch	0.95%
Price vs 200-day SMA	-7.36%
RSI	56.58
RSI Monthly	47.81
RSI Weekly	45.21
Sharpe ratio	0.46x
Sortino ratio	0.83
Total Return	1.75%
Tr YTD	-16.43
Tr1m	11.29%
Tr1w	4.42%
Tr3m	-28.66%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 6.2B
Operating Income Growth	0.44
Operating Income Growth Q	52.33
Operating Income Growth3 Y	13.46
Operating Income Growth5 Y	28.96
Operating margin	30.26

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	133,400,033%
Net Borrowing	9,190,015,000
Shares Insiders	0.82%
Shares Institutions	9.68%
Shares Out	262,809,800
Shares Qo Q	0.84%
Shares Yo Y	-0.67%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 5.9B
Average Volume	2,955,845.2x
Bv Per Share	90.48
CAPEX	TWD -1.3B
Ch10y	271.9
Ch1m	11.29
Ch1w	4.42
Ch1y	5.11
Ch3m	-28.66
Ch3y	-15.99
Ch5y	213.2
Ch6m	-15.23
Change	1.5%
Change From Open	0.85
Close	233
Days Gap	0.64
Depreciation Amortization	1,402,416,000
Dollar Volume	1,431,584,874.5
Earnings Date	2026-08-13
EBIT	TWD 6.2B
EBITDA	TWD 7.6B
EPS	TWD 18.04
F Score	4
FCF	TWD 6.2B
FCF EV Yield	6.05x
FCF Per Share	TWD 23.45
Financing CF	6,896,146,000
Fiscal Year End	December
Founded	1,966
Goodwill	31,954,931,000
Graham Number	191.64318
Graham Upside	-18.97
Income Tax	TWD 998.1M
Investing CF	-12,467,896,000
Is Primary Listing	1
Last Earnings Date	2025-11-06
Last Report Date	2025-12-31
Lynch Fair Value	TWD 451
Lynch Upside	90.7
Ma150	271.9
Ma150ch	-13%
Ma20	227.6
Ma20ch	3.91%
Net CF	1,709,504,000
Next Earnings Date	2026-08-13
Open	234.5
P FCF Ratio	10.09
P OCF Ratio	8.31
Payment Date	2025-09-05
Position In Range	42.11
Ppne	7,606,864,000
Price Date	2026-05-08
Price EBITDA	TWD 8.17
Relative Volume	2.21x
Revenue	20,509,474,000x
SBC By Revenue	1.36x
Share Based Comp	279,377,000
Tax By Revenue	4.87x
Tax Rate	17.46%
Tr6m	-15.23%
Volume	6,053,213
Z Score	1.17

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPE/1795 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$2.56 annual per share

Payout ratio

+32.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+75.2%

6 consecutive years of growth

Total shareholder yield

+1.8%

Next ex-dividend date: 2025-08-11

Performance

TPE/1795 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPE/1795?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.7%

Share of float held by funds and institutions

Insider ownership

+0.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.7%

Negative means the company is buying back shares.

Technical

TPE/1795 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.6

Neutral momentum band

Price vs 200-day MA

-7.4%

50/200-day relationship not available

Beta (5Y)

0.49

Less volatile than the market

Sharpe ratio

0.46

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPE/1795

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpe/1795 stock rating?

tpe/1795 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpe/1795 analysis?

The full report lives at /stocks/tpe/1795/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpe/1795?

The latest report frames tpe/1795 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpe/1795 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.